GAMARET NEO, intramaminė suspensija
GAMARET NEO, intramaminė suspensija
Authorised
- Oxacillin sodium monohydrate
- Ampicillin sodium
Product identification
Medicine name:
GAMARET NEO, intramaminė suspensija
Active substance:
- Oxacillin sodium monohydrate
- Ampicillin sodium
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Oxacillin sodium monohydrate200.00milligram(s)1.00Syringe
-
Ampicillin sodium200.00milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat7day
-
Milk6day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CR50
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/01/1344/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Lithuanian (PDF)
Published on: 20/03/2024
How useful was this page?: